Recent studies indicated that ME2 was dysregulated in several tumors and serves as a target in the regulation of tumor proliferation, differentiation, metabolism, and invasion in various cancers, such as lung cancer, pancreatic cancer, and erythroleukemia.12, 17, 18. Here, ME2 is linked to pancreatic neoplasm.